https://www.selleckchem.com/products/euk-134.html
11; 95% CI, 1.78-5.43), as did those with hemoglobin 10mg/dL (HR, 4.32; 95% CI, 2.23-8.36). Patients with baseline KPS90% showed significantly worse DFS (HR, 2.83; 95% CI, 1.60-5.01), as did those with hemoglobin 10mg/dL (HR, 4.16; 95% CI, 2.17-7.95). For stage IIIB cervical cancer, treatment with CRT offers a significant benefit in DFS and OS compared with treatment with RT only. For stage IIIB cervical cancer, treatment with CRT offers a significant benefit in DFS and OS compared with treatment with RT only.Rolling Element
Like
Comment
Share
